Abstract
Acetylcholinesterase inhibitors are currently of high interest due to the many reasons. Among them, Alzheimers disease drugs are of great interest. In this study, eleven monoquaternary pyridinium salts substituted by different groups (electron donors and electron acceptors) in position four were prepared. Then, their anticholinesterase activity was tested. As observed, their IC50s ranged from 33 μM to 3981 μM. Moreover, probability of blood-brain barrier penetration was predicted.
Keywords: Quaternary ammonium salts, pyridinium salts, inhibitor, cholinesterase, Alzheimer's disease, prophylaxis
Letters in Organic Chemistry
Title: Preparation and In Vitro Evaluation of Monoquaternary Inhibitors of Brain Cholinesterases
Volume: 6 Issue: 6
Author(s): Daniel Jun, Martin Paar, Jiri Binder, Jan Marek, Miroslav Pohanka, Petr Stodulka and Kamil Kuca
Affiliation:
Keywords: Quaternary ammonium salts, pyridinium salts, inhibitor, cholinesterase, Alzheimer's disease, prophylaxis
Abstract: Acetylcholinesterase inhibitors are currently of high interest due to the many reasons. Among them, Alzheimers disease drugs are of great interest. In this study, eleven monoquaternary pyridinium salts substituted by different groups (electron donors and electron acceptors) in position four were prepared. Then, their anticholinesterase activity was tested. As observed, their IC50s ranged from 33 μM to 3981 μM. Moreover, probability of blood-brain barrier penetration was predicted.
Export Options
About this article
Cite this article as:
Jun Daniel, Paar Martin, Binder Jiri, Marek Jan, Pohanka Miroslav, Stodulka Petr and Kuca Kamil, Preparation and In Vitro Evaluation of Monoquaternary Inhibitors of Brain Cholinesterases, Letters in Organic Chemistry 2009; 6 (6) . https://dx.doi.org/10.2174/157017809789124876
DOI https://dx.doi.org/10.2174/157017809789124876 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Partial Dopamine Agonists and the Treatment of Psychosis
Current Neuropharmacology Epidemiology of Psychotic Symptoms during Pregnancy and Postpartum in Women with Schizophrenia
Current Women`s Health Reviews Biochemical and Therapeutic Effects of Antioxidants in the Treatment of Alzheimers Disease, Parkinsons Disease, and Amyotrophic Lateral Sclerosis
Current Drug Targets - CNS & Neurological Disorders Computational Methods for the Prediction of Microbial Essential Genes
Current Bioinformatics May Patients with Alcohol Liver Disease Benefit from Herbal Medicines?
Reviews on Recent Clinical Trials Kv1.3 Lymphocyte Potassium Channel Inhibition as a Potential Novel Therapeutic Target in Acute Ischemic Stroke
CNS & Neurological Disorders - Drug Targets Meet Our Editorial Board Member
CNS & Neurological Disorders - Drug Targets Premorbid and Illness-related Social Difficulties in Eating Disorders: An Overview of the Literature and Treatment Developments
Current Neuropharmacology Meet Our Editorial Board Member
Current Alzheimer Research Mechanisms and Medical Management of Exercise Intolerance in Hypertrophic Cardiomyopathy
Current Pharmaceutical Design Magnetic Nanoparticles Utilized in Hemodialysis for the Treatment of Hyperhomocysteinemia:The New Challenge of Nanobiotechnology
Current Nanoscience Child and Adolescent Refugee Mental Health in Brazil: Literature Review and a Family Case Report
Adolescent Psychiatry Crohns Targeted Therapy: Myth or Real Goal?
Current Drug Discovery Technologies Safety and Efficacy of Baclofen in the Treatment of Alcohol-Dependent Patients
Current Pharmaceutical Design Psychoimmunological Analysis of Cancer Patients: Correlation with the Prognosis
Current Aging Science Editorial [Hot Topic: Cyclooxygenases and Cyclooxygenase Inhibitors in Neurological and Psychiatric Diseases (Executive Editor: Luisa Minghetti) ]
Current Pharmaceutical Design Smoking and Hypertension: Independent or Additive Effects to Determining Vascular Damage?
Current Vascular Pharmacology Ontogenetic Variation of the Human Genome
Current Genomics Dystonia Associated with Lamotrigine Therapy: A Case Report and Review of the Literature
Current Drug Safety Thyroid Hormone Treatment for Differentiated Thyroid Carcinoma: What Drug, How Long, What Dose?
Current Cancer Therapy Reviews